The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final results from a trial of a combination herbal supplement for biochemically recurrent prostate cancer.
Tanya B Dorff
No relevant relationships to disclose
Denice D Tsao-Wei
No relevant relationships to disclose
Debra Hawes
No relevant relationships to disclose
Shigang Xiong
No relevant relationships to disclose
David I. Quinn
No relevant relationships to disclose
Mitchell E. Gross
No relevant relationships to disclose
Gary Lieskovsky
No relevant relationships to disclose
Nicholas J. Vogelzang
No relevant relationships to disclose
Susan G. Groshen
No relevant relationships to disclose
Jacek K. Pinski
Employment or Leadership Position - OncoNatural Solutions (U)
Consultant or Advisory Role - OncoNatural Solutions (U)
Stock Ownership - OncoNatural Solutions